An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.
16 Sep, 2021 | 10:13h | UTCProtection of BNT162b2 Vaccine Booster against Covid-19 in Israel – New England Journal of Medicine